Rolls-Royce's artificial intelligence system, known as "Eleanor," offers a peek into how it sees the ultra-wealthy getting around. » Read More
Jim Cramer warned investors to keep their powder dry on this stock, before a tweeting politician has a field day on it.
Asia opened lower on Friday, after most local markets remained near-unchanged this week ahead of a speech by the Fed chair.
Jim Cramer explained why he chooses not to speculate the Fed when he makes the next investment for his charitable trust.
Jim Cramer says executive embarrassment and presidential candidate tweets won’t solve the EpiPen problem.
The risk to markets is that Fed Chair Janet Yellen simply sounds more ready than markets expect to raise rates.
Donald Trump's pivot to Mr. Nice Guy must've completely freaked out Hillary Clinton, says Jake Novak—enough so that she felt the need to remind the world of all the bad things he's said!
The "Fast Money" traders made their last few bets ahead of Federal Reserve Chair Janet Yellen's Friday speech in Jackson Hole, Wyoming.
Jim Cramer says it's time for Apple to put its massive $231 billion cash hoard to work, and buy this company.
Jim Cramer isn't worried about the Fed, he says it's usually wrong.
How should investors make money in a low-volatility, low-volume market? The answer may be taking defensive measures.
Check out the companies making headlines after the bell on Thursday.
If Mylan's CEO wants to lower the price of the EpiPen today, she could, Express Scripts' Dr. Steve Miller says.
A new regulation from the Labor Department will widen access to state-based IRA programs.
The FDA and Congress enabled Mylan to secure a monopoly on EpiPens and then jack up the prices, says this intellectual-property expert.
El-Erian made his comments ahead of Fed Chair Janet Yellen's speech, scheduled for Friday morning in Jackson Hole, Wyoming.
The savings came under a program where health providers coordinate care for 7.7 million Medicare beneficiaries.
The "Halftime Report" traders weigh in on hedge fund industry redemptions and fee structure.
Elena Delle Donne nearly walked off the court for good, until she learned a valuable lesson from being overworked.
Obamacare rates are 7 percent less in states with greater Medicaid eligibility, a new analysis says.
Shares of St. Jude Medical briefly fell more than 8 percent Thursday after Muddy Waters Capital announced the firm is short the stock.
Jim Cramer reveals why he chooses not to speculate the Fed when he makes his next investment.
The "Fast Money" traders give you 4 ways to trade the upcoming Fed meeting.
Heather Bresch, Mylan CEO, responds to the controversy surround the company's 400-percent increase for its injectable allergy medicine.
Check out this mashup of some of Suze Orman's best advice and make sure to watch The Susan Orman Show series finale on Saturday, March 28 9p ET.
In the series finale, Oprah Winfrey tells Suze she knew from the very first time she was on her show, that Suze was destined to do something special.
Suze Orman offers a behind the scenes look at her show.